US 8877725
Peptide conjugated, inosine-substituted antisense oligomer compound and method
granted A61KA61K48/0008A61P
Quick answer
US patent 8877725 (Peptide conjugated, inosine-substituted antisense oligomer compound and method) held by Sarepta Therapeutics, Inc. expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K48/0008, A61P, A61P13/12, A61P31/12